These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

555 related items for PubMed ID: 15173268

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of oral snus and medicinal nicotine in smokers on toxicant exposure and withdrawal symptoms: a feasibility study.
    Kotlyar M, Hertsgaard LA, Lindgren BR, Jensen JA, Carmella SG, Stepanov I, Murphy SE, Hecht SS, Hatsukami DK.
    Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):91-100. PubMed ID: 21068204
    [Abstract] [Full Text] [Related]

  • 3. Effects of reduced cigarette smoking on the uptake of a tobacco-specific lung carcinogen.
    Hecht SS, Murphy SE, Carmella SG, Zimmerman CL, Losey L, Kramarczuk I, Roe MR, Puumala SS, Li YS, Le C, Jensen J, Hatsukami DK.
    J Natl Cancer Inst; 2004 Jan 21; 96(2):107-15. PubMed ID: 14734700
    [Abstract] [Full Text] [Related]

  • 4. Metabolites of a tobacco-specific nitrosamine, 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanone (NNK), in the urine of smokeless tobacco users: relationship between urinary biomarkers and oral leukoplakia.
    Kresty LA, Carmella SG, Borukhova A, Akerkar SA, Gopalakrishnan R, Harris RE, Stoner GD, Hecht SS.
    Cancer Epidemiol Biomarkers Prev; 1996 Jul 21; 5(7):521-5. PubMed ID: 8827356
    [Abstract] [Full Text] [Related]

  • 5. Similar exposure to a tobacco-specific carcinogen in smokeless tobacco users and cigarette smokers.
    Hecht SS, Carmella SG, Murphy SE, Riley WT, Le C, Luo X, Mooney M, Hatsukami DK.
    Cancer Epidemiol Biomarkers Prev; 2007 Aug 21; 16(8):1567-72. PubMed ID: 17684130
    [Abstract] [Full Text] [Related]

  • 6. Randomised clinical trial of snus versus medicinal nicotine among smokers interested in product switching.
    Hatsukami DK, Severson H, Anderson A, Vogel RI, Jensen J, Broadbent B, Murphy SE, Carmella S, Hecht SS.
    Tob Control; 2016 May 21; 25(3):267-74. PubMed ID: 25991608
    [Abstract] [Full Text] [Related]

  • 7. Metabolites of a tobacco-specific lung carcinogen in nonsmoking women exposed to environmental tobacco smoke.
    Anderson KE, Carmella SG, Ye M, Bliss RL, Le C, Murphy L, Hecht SS.
    J Natl Cancer Inst; 2001 Mar 07; 93(5):378-81. PubMed ID: 11238699
    [Abstract] [Full Text] [Related]

  • 8. Analysis of human urine for pyridine-N-oxide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific lung carcinogen.
    Carmella SG, Borukhova A, Akerkar SA, Hecht SS.
    Cancer Epidemiol Biomarkers Prev; 1997 Feb 07; 6(2):113-20. PubMed ID: 9037562
    [Abstract] [Full Text] [Related]

  • 9. Similar uptake of lung carcinogens by smokers of regular, light, and ultralight cigarettes.
    Hecht SS, Murphy SE, Carmella SG, Li S, Jensen J, Le C, Joseph AM, Hatsukami DK.
    Cancer Epidemiol Biomarkers Prev; 2005 Mar 07; 14(3):693-8. PubMed ID: 15767351
    [Abstract] [Full Text] [Related]

  • 10. Nicotine and Toxicant Exposure among U.S. Smokeless Tobacco Users: Results from 1999 to 2012 National Health and Nutrition Examination Survey Data.
    Rostron BL, Chang CM, van Bemmel DM, Xia Y, Blount BC.
    Cancer Epidemiol Biomarkers Prev; 2015 Dec 07; 24(12):1829-37. PubMed ID: 26582044
    [Abstract] [Full Text] [Related]

  • 11. Potential reduced exposure products (PREPs) for smokeless tobacco users: clinical evaluation methodology.
    Gray JN, Breland AB, Weaver M, Eissenberg T.
    Nicotine Tob Res; 2008 Sep 07; 10(9):1441-8. PubMed ID: 19023835
    [Abstract] [Full Text] [Related]

  • 12. A comparison of urinary biomarkers of tobacco and carcinogen exposure in smokers.
    Murphy SE, Link CA, Jensen J, Le C, Puumala SS, Hecht SS, Carmella SG, Losey L, Hatsukami DK.
    Cancer Epidemiol Biomarkers Prev; 2004 Oct 07; 13(10):1617-23. PubMed ID: 15466978
    [Abstract] [Full Text] [Related]

  • 13. A two-site, two-arm, 34-week, double-blind, parallel-group, randomized controlled trial of reduced nicotine cigarettes in smokers with mood and/or anxiety disorders: trial design and protocol.
    Allen SI, Foulds J, Pachas GN, Veldheer S, Cather C, Azzouz N, Hrabovsky S, Hameed A, Yingst J, Hammett E, Modesto J, Krebs NM, Zhu J, Liao J, Muscat JE, Richie J, Evins AE.
    BMC Public Health; 2017 Jan 19; 17(1):100. PubMed ID: 28103841
    [Abstract] [Full Text] [Related]

  • 14. Tobacco Consumption and Toxicant Exposure of Cigarette Smokers Using Electronic Cigarettes.
    Pulvers K, Emami AS, Nollen NL, Romero DR, Strong DR, Benowitz NL, Ahluwalia JS.
    Nicotine Tob Res; 2018 Jan 05; 20(2):206-214. PubMed ID: 28003511
    [Abstract] [Full Text] [Related]

  • 15. Exposure to a Tobacco-Specific Carcinogen Among Adolescent Smokeless Tobacco Users in Rural California, United States.
    Chaffee BW, Jacob P, Couch ET, Benowitz NL.
    Nicotine Tob Res; 2020 Oct 08; 22(10):1764-1771. PubMed ID: 31504879
    [Abstract] [Full Text] [Related]

  • 16. Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation.
    Hecht SS, Carmella SG, Chen M, Dor Koch JF, Miller AT, Murphy SE, Jensen JA, Zimmerman CL, Hatsukami DK.
    Cancer Res; 1999 Feb 01; 59(3):590-6. PubMed ID: 9973205
    [Abstract] [Full Text] [Related]

  • 17. A study to evaluate the effect on Mouth Level Exposure and biomarkers of exposure estimates of cigarette smoke exposure following a forced switch to a lower ISO tar yield cigarette.
    Shepperd CJ, Eldridge AC, Errington G, Dixon M.
    Regul Toxicol Pharmacol; 2011 Dec 01; 61(3 Suppl):S13-24. PubMed ID: 21672597
    [Abstract] [Full Text] [Related]

  • 18. Exposure to Toxicants Associated With Use and Transitions Between Cigarettes, e-Cigarettes, and No Tobacco.
    Dai H, Benowitz NL, Achutan C, Farazi PA, Degarege A, Khan AS.
    JAMA Netw Open; 2022 Feb 01; 5(2):e2147891. PubMed ID: 35142830
    [Abstract] [Full Text] [Related]

  • 19. Toxicant exposure in cigarette reducers versus light smokers.
    Hatsukami DK, Le CT, Zhang Y, Joseph AM, Mooney ME, Carmella SG, Hecht SS.
    Cancer Epidemiol Biomarkers Prev; 2006 Dec 01; 15(12):2355-8. PubMed ID: 17164356
    [Abstract] [Full Text] [Related]

  • 20. Quantitation of metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone after cessation of smokeless tobacco use.
    Hecht SS, Carmella SG, Ye M, Le KA, Jensen JA, Zimmerman CL, Hatsukami DK.
    Cancer Res; 2002 Jan 01; 62(1):129-34. PubMed ID: 11782369
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.